Kelly Huber

495 total citations
13 papers, 428 citations indexed

About

Kelly Huber is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Kelly Huber has authored 13 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Virology, 9 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Kelly Huber's work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). Kelly Huber is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). Kelly Huber collaborates with scholars based in United States, Canada and Switzerland. Kelly Huber's co-authors include Nicolas Sluis‐Cremer, John W. Mellors, Geneviève Doyon, Elizabeth Fyne, Grant D. Schauer, Sanford H. Leuba, Stephen Chan, Stewart G. Martin, P. Richard Harrigan and Lei Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Kelly Huber

12 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Huber United States 9 252 220 180 63 55 13 428
Kazuki Izumi Japan 11 232 0.9× 204 0.9× 190 1.1× 41 0.7× 35 0.6× 20 411
Pratiq A. Patel United States 7 301 1.2× 295 1.3× 268 1.5× 54 0.9× 38 0.7× 7 412
Lily Hong United States 5 232 0.9× 169 0.8× 201 1.1× 45 0.7× 53 1.0× 8 480
Isaac Zentner United States 14 148 0.6× 194 0.9× 229 1.3× 83 1.3× 51 0.9× 20 484
Takuya Kobayakawa Japan 11 165 0.7× 180 0.8× 191 1.1× 103 1.6× 22 0.4× 44 378
S.L. Irving United Kingdom 7 218 0.9× 186 0.8× 326 1.8× 152 2.4× 43 0.8× 8 547
Valérie Vivet‐Boudou France 13 266 1.1× 192 0.9× 370 2.1× 45 0.7× 86 1.6× 27 595
Valentine V. Courouble United States 7 151 0.6× 143 0.7× 92 0.5× 19 0.3× 27 0.5× 9 281
Lihong Zhou United Kingdom 11 167 0.7× 122 0.6× 319 1.8× 16 0.3× 64 1.2× 24 503
Joseph S. Redman United States 8 89 0.4× 81 0.4× 155 0.9× 29 0.5× 57 1.0× 11 303

Countries citing papers authored by Kelly Huber

Since Specialization
Citations

This map shows the geographic impact of Kelly Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Huber more than expected).

Fields of papers citing papers by Kelly Huber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Huber. The network helps show where Kelly Huber may publish in the future.

Co-authorship network of co-authors of Kelly Huber

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Huber. A scholar is included among the top collaborators of Kelly Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Huber. Kelly Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hayashi, Madoka, et al.. (2022). BLOSSoM: Improving Human Milk Provision in Preterm Infants Through Texting Support. Pediatric Quality and Safety. 7(5). e600–e600.
2.
Barnard, John P., Kelly Huber, & Nicolas Sluis‐Cremer. (2019). Nonnucleoside Reverse Transcriptase Inhibitor Hypersusceptibility and Resistance by Mutation of Residue 181 in HIV-1 Reverse Transcriptase. Antimicrobial Agents and Chemotherapy. 63(8). 4 indexed citations
3.
La, Jennifer, Catherine F. Latham, Adam Johnson, et al.. (2015). Identification of mechanistically distinct inhibitors of HIV-1 reverse transcriptase through fragment screening. Proceedings of the National Academy of Sciences. 112(22). 6979–6984. 23 indexed citations
4.
Schauer, Grant D., Kelly Huber, Sanford H. Leuba, & Nicolas Sluis‐Cremer. (2014). Mechanism of allosteric inhibition of HIV-1 reverse transcriptase revealed by single-molecule and ensemble fluorescence. Nucleic Acids Research. 42(18). 11687–11696. 39 indexed citations
5.
Sluis‐Cremer, Nicolas, Kelly Huber, Chanson J. Brumme, & P. Richard Harrigan. (2014). Competitive Fitness Assays Indicate that the E138A Substitution in HIV-1 Reverse Transcriptase Decreases In Vitro Susceptibility to Emtricitabine. Antimicrobial Agents and Chemotherapy. 58(4). 2430–2433. 6 indexed citations
6.
Sluis‐Cremer, Nicolas, Michael R. Jordan, Kelly Huber, et al.. (2014). E138A in HIV-1 reverse transcriptase is more common in subtype C than B: Implications for rilpivirine use in resource-limited settings. Antiviral Research. 107. 31–34. 54 indexed citations
7.
Doyon, Geneviève, Michele D. Sobolewski, Kelly Huber, et al.. (2014). Discovery of a Small Molecule Agonist of Phosphatidylinositol 3-Kinase p110α That Reactivates Latent HIV-1. PLoS ONE. 9(1). e84964–e84964. 25 indexed citations
8.
Xu, Hongzhan, Gregory A. Gibson, Kelly Huber, et al.. (2013). Evidence for biphasic uncoating during HIV-1 infection from a novel imaging assay. Retrovirology. 10(1). 70–70. 67 indexed citations
9.
Rothstein, Sam N., Kelly Huber, Nicolas Sluis‐Cremer, & Steven R. Little. (2013). In Vitro Characterization of a Sustained-Release Formulation for Enfuvirtide. Antimicrobial Agents and Chemotherapy. 58(3). 1797–1799. 10 indexed citations
10.
Brumme, Chanson J., Kelly Huber, Winnie Dong, et al.. (2013). Replication Fitness of Multiple Nonnucleoside Reverse Transcriptase-Resistant HIV-1 Variants in the Presence of Etravirine Measured by 454 Deep Sequencing. Journal of Virology. 87(15). 8805–8807. 6 indexed citations
11.
Huber, Kelly, et al.. (2011). Inhibitors of Histone Deacetylases. Journal of Biological Chemistry. 286(25). 22211–22218. 117 indexed citations
12.
Ahn, Jin-Woo, In‐Ja L. Byeon, Kelly Huber, et al.. (2010). The RNA binding protein HuR does not interact directly with HIV-1 reverse transcriptase and does not affect reverse transcription in vitro. Retrovirology. 7(1). 40–40. 9 indexed citations
13.
Huber, Kelly, Poulam M. Patel, Lei Zhang, et al.. (2008). 2-[(1-Methylpropyl)dithio]-1H-imidazole inhibits tubulin polymerization through cysteine oxidation. Molecular Cancer Therapeutics. 7(1). 143–151. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuki Izumi Breakdown of academic impact, for papers by Pratiq A. Patel Breakdown of academic impact, for papers by Lily Hong Breakdown of academic impact, for papers by Isaac Zentner Breakdown of academic impact, for papers by Takuya Kobayakawa Breakdown of academic impact, for papers by S.L. Irving Breakdown of academic impact, for papers by Valérie Vivet‐Boudou Breakdown of academic impact, for papers by Valentine V. Courouble Breakdown of academic impact, for papers by Lihong Zhou Breakdown of academic impact, for papers by Joseph S. Redman
Rankless by CCL
2026